Nigeria Immunization FHIR IG, published by intellisoftkenya.com. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/Nigeria-Immunization-FHIR-IG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: NEIR ValueSet for Clinical Status - JSON Representation

Active as of 2025-08-11

Raw json | Download

{
  "resourceType" : "ValueSet",
  "id" : "neir-clinical-status-vs",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet neir-clinical-status-vs</b></p><a name=\"neir-clinical-status-vs\"> </a><a name=\"hcneir-clinical-status-vs\"> </a><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.5.0/CodeSystem-allergyintolerance-clinical.html\"><code>http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"http://terminology.hl7.org/6.5.0/CodeSystem-allergyintolerance-clinical.html#allergyintolerance-clinical-active\">active</a></td><td style=\"color: #cccccc\">Active</td><td>The subject is currently experiencing, or is at risk of, a reaction to the identified substance.</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.5.0/CodeSystem-allergyintolerance-clinical.html#allergyintolerance-clinical-inactive\">inactive</a></td><td style=\"color: #cccccc\">Inactive</td><td>The subject is no longer at risk of a reaction to the identified substance.</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.5.0/CodeSystem-allergyintolerance-clinical.html#allergyintolerance-clinical-resolved\">resolved</a></td><td style=\"color: #cccccc\">Resolved</td><td>A reaction to the identified substance has been clinically reassessed by testing or re-exposure and is considered no longer to be present. Re-exposure could be accidental, unplanned, or outside of any clinical setting.</td></tr></table></li></ul></div>"
  },
  "url" : "http://nhin.example.ng/ValueSet/neir-clinical-status-vs",
  "version" : "0.1.0",
  "name" : "NEIRClinicalStatusVS",
  "title" : "NEIR ValueSet for Clinical Status",
  "status" : "active",
  "experimental" : false,
  "date" : "2025-08-11T12:02:23+00:00",
  "publisher" : "intellisoftkenya.com",
  "contact" : [
    {
      "name" : "intellisoftkenya.com",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://www.intellisoftkenya.com/"
        }
      ]
    },
    {
      "name" : "IntelliSOFT Consulting Kenya.",
      "telecom" : [
        {
          "system" : "email",
          "value" : "info@intellisoftkenya.com",
          "use" : "work"
        }
      ]
    }
  ],
  "description" : "ValueSet for Clinical Status from NEIR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "NG",
          "display" : "Nigeria"
        }
      ]
    }
  ],
  "compose" : {
    "include" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
        "concept" : [
          {
            "code" : "active"
          },
          {
            "code" : "inactive"
          },
          {
            "code" : "resolved"
          }
        ]
      }
    ]
  }
}